Navigation Links
US Oncology Reports Second Quarter Operating Results
Date:8/6/2009

2,866 Depreciation and amortization 25,172 25,883 25,098 50,270 51,637 Amortization of stock compensation 268 565 569 837 1,120 Other (income) expense (37) 2 - (37) (1,369) ---- - - ---- ------- EBITDA 39,912 56,927 53,669 93,581 (272,216) Plus: Loss on early extinguishment of debt 22,353 - - 22,353 - Impairment and restructuring charges 381 464 1,409 1,790 381,770 Other non-cash charges 65 - - 65 - -- - - -- - Adjusted EBITDA 62,711 57,391 55,078 117,789 109,554 Changes in assets and liabilities 4,301 (39,853) (3,205) 1,096 (15,814) Deferred income tax provision (benefit) (3,324) 44 5,380 2,056 (2,016) Interest expense, net (22,484) (22,433) (22,622) (45,106) (46,633) Income tax benefit (provision) 1,324 (3,788) (3,604) (2,280) (2,866) ----- ------- ------- ------- ------- Net cash provided by (used in) operating activities $42,528 $(8,639) $31,027 $73,555 $42,225 ======= ======= ======= ======= =======


'/>"/>
SOURCE US Oncology, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25

Related medicine news :

1. US Oncology Announces Retirement of R. Dale Ross and Appointment of Bruce Broussard as Chairman of the Board
2. Journal of Clinical Oncology Publishes TREANDA Study Demonstrating Significant Improvement in Overall Response and Progression-Free Survival in Chronic Lymphocytic Leukemia
3. Tampa Bay Radiation Oncology Announces New Full Service Center at Bruce B Downs
4. The Community Oncology Alliance Responds to President Obamas Press Conference Comments Regarding Cancer Patients
5. PRA International to Host Audio Conference: Oncology Trials in 2009 - Challenges & Innovative Approaches
6. US Oncology to Report 2009 Second Quarter Operating Results
7. US Oncology Research Network Participates in Phase III Follow-up Study to BiPars Investigational Cancer Drug BSI-201
8. Perceptive Informatics Enhances CNS and Oncology Medical Image Processing and Analysis Capabilities Through Alliance With Biospective
9. Oncology Groups Pharmaceutical Services Agreement Enhances Efficiency of Drug Management Program
10. MDOUTLOOK(R) Quick Polls Report on Clinical Integration of Key Oncology Developments Following ASCO 2009
11. US Oncology Offers Electronic Health Records Informative Webinar
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2014)... NY In a review published in the April ... president of The Feinstein Institute for Medical Research, says ... medical community,s approach to treating sepsis, which ... Americans. , Sepsis occurs when molecules released into the ... throughout the body. Inflammation is necessary for maintaining good ...
(Date:4/17/2014)... Doctors who treat patients with a severe and ... an agonizing treatment decision. , The drug sirolimus ... relieve shortness of breath. But some patients eventually ... potentially fatal complications following transplantation. , "It,s a ... director of Loyola University Medical Center,s LAM Clinic ...
(Date:4/17/2014)... Calif., April 17, 2014 By discovering a new ... after a stroke, researchers at UC Irvine and the ... that may limit or prevent stroke-induced brain damage. , ... fourth-leading cause of death and primary reason for disability ... in a stroke and lets blood-borne material into the ...
(Date:4/17/2014)... online has the potential to ward off depression among ... research published online in The Journals of ... . In the article " Internet Use and Depression ... Longitudinal Analysis ," the authors report that Internet use ... percent among their study sample. , Late-life depression ...
(Date:4/17/2014)... April 17, 2014 Meaningful long-term survival is ... of the abdomen when treated with cytoreductive surgery ... a first-of-its-size analysis by physicians at Wake Forest ... the largest reported, single-center experience with cytoreductive surgery ... M.D., and analysis of 20 years, worth of ...
Breaking Medicine News(10 mins):Health News:Feinstein Institute researcher publishes new perspective on sepsis 2Health News:Patients with rare lung disease face agonizing treatment dilemma 2Health News:Patients with rare lung disease face agonizing treatment dilemma 3Health News:Study IDs new cause of brain bleeding immediately after stroke 2Health News:Internet use may cut retirees' depression 2Health News:20 years of data shows treatment technique improvement for advanced abdominal cancer 2
... Yarl’s Wood one of the country's biggest immigration detention ... long-term detainees, according to the report of the prison ... launched an inquiry into healthcare at Yarl's Wood Immigration ... treatment of two female asylum seekers from Uganda. ...
... A ban on smoking cigarettes in public places such as ... recommendation// made by a panel consisting of members from the ... that about 3000 to 5000 people exposed to passive smoking ... However a statutory ban on smoking in France could trigger ...
... introduced a new medical device to facilitate the ... ,The Cuban-made equipment, Digital ANGIODIN PD-3000 ... dysfunction and micro and macro vessel failures at ... Tuesday. ,The equipment is simple in ...
... Nobel prize for medicine has been conferred on two Americans, ... of the Harvard University//, for their discovery of ‘RNA interference’, ... humans. , ‘RNA interference’ involves the silencing ... role in the regulation of gene expression, controls the activity ...
... announced on Tuesday the acquisition of Pinewood Laboratories// Limited ... broaden its presence in the European market. ,'This ... over Britain, Ireland and Germany,' Wockhardt chairman Habil Khorakiwala ... million, accounting for almost half of Wockhardt's total sales,' ...
... after the devastating earthquake of 8 October 2005 in ... at risk, facing a second winter without permanent shelter.// ... left around 3.5 million homeless. Estimates have shown that ... while recent landslides and flooding have left most quake ...
Cached Medicine News:Health News:Nobel Prize for Gene ‘Silencing 2Health News:Survivors of Pakistan Earthquake Still at Risk 2
(Date:1/15/2014)... WORTH, Texas , Jan. 15, 2014  Humberto C. ... Dermatology Achievement Award" from the Journal of Drugs ... Aesthetic & Clinical Conference (ODAC). The event is January 17-20, ... Florida . The ODAC ...
(Date:1/15/2014)...  Manufacturers, suppliers and distributors of innovative medical-related products ... most important business assets, intellectual property (IP). ... Because of the highly-competitive nature of the Medical ... most litigious industry sectors of cases involving IP ...
(Date:1/15/2014)... Medical is very pleased to announce the appointment of Mr. ... Officer.  Mark was promoted from his current role of Chief ... facilities in Massachusetts , Mississippi ... in 2012 with 20+ years of broad-based operations, sales, engineering ...
Breaking Medicine Technology:Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4Intellectual Property Insurance for Medical-related Products and Services 2Tegra Medical Appoints New Chief Executive Officer 2Tegra Medical Appoints New Chief Executive Officer 3
... Mich. , May 19 Stryker Corporation (NYSE: ... has informed the Company that the actions undertaken to address issues raised ... , , , ... Warning Letter from FDA regarding compliance with certain quality system requirements at ...
... SAN FRANCISCO, Calif. , May 19 ... studies was published in The Lancet on ... elevated levels of lipoprotein-associated phospholipase A2 (Lp-PLA2), a vascular-specific ... coronary heart disease similar in magnitude to that with ...
Cached Medicine Technology:Stryker Announces Resolution of Two FDA Warning Letters 2Large Meta-Analysis Further Validates Benefit of Measuring Lp-PLA2 for Coronary Heart Disease and Ischemic Stroke Risk Assessment 2Large Meta-Analysis Further Validates Benefit of Measuring Lp-PLA2 for Coronary Heart Disease and Ischemic Stroke Risk Assessment 3
Malaria device / strip (2 line, P.f.-HRP2 Test)...
... Trinity Biotech Uni-Gold™ Pf Malaria Test ... vitro, the presence of Plasmodium ... test is an antigen-capture assay detecting ... histidine- rich protein II (PfHRP- II), ...
High sensitive, specific one step immunochromatographic assay for human infectious disease...
High sensitive, specific one step immunochromatographic assay for human infectious disease...
Medicine Products: